Schematic illustration of nucleic acid detection by the conventional CRISPR assay and the asymmetric CRISPR assay. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-43389-7 Changchun Liu, ...
The game’s afoot for CRISPR diagnostic developer Sherlock Biosciences. The company hopes to speed up its path to market through the acquisition of the rapid test maker Sense Biodetection. Based in ...
Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...
Coronavirus Disease 2019 (COVID-19) has driven the use of nucleic acid testing technology in clinical testing. There is a growing need for point-of-care testing (POCT) devices that can integrate ...
The COVID pandemic was a make or break moment for many a biotech. At Mammoth Biosciences, it may have been a little of both. For Janice Chen, Ph.D., the CRISPR biotech's chief technology officer and ...
Researchers have developed a fast, specific and reliable test for mpox infection, combining CRISPR/Cas12a and nanopore sensing. Research presented at the 68th Biophysical Society Annual Meeting (10-14 ...
Newser on MSN
World's Rarest Blood Type May Soon Be Lab-Grown
Scientists are working to grow the rarest blood type in the world in a lab, an effort that could have huge ramifications for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback